Medical Malpractice Litigation in Non–Mesh-Related Pelvic Organ Prolapse Surgery: An Analysis of 91 Cases. Issue 4 (April 2021)

• Record Type: Journal Article
• Authors: Yao, Benjamin; Slopnick, Emily; Sheyn, David; Chapman, Graham; El-Nashar, Sherif; Hijaz, Adonis; Mahajan, Sangeeta
• Is Part Of: Female pelvic medicine & reconstructive surgery. Volume 27:Issue 4(2021)
• Page Start: 255
• Page End: 259
• Publication Date: 2021-04
• Subjects: malpractice -- litigation -- pelvic organ prolapse -- complications -- verdict; Pelvis -- Diseases -- Periodicals; Pelvis -- Surgery -- Periodicals; Genital Diseases, Female -- surgery -- Periodicals; Urologic Diseases -- surgery -- Periodicals; Colonic Diseases -- surgery -- Periodicals; Rectal Diseases -- surgery -- Periodicals; Surgical Procedures, Operative -- methods -- Periodicals; 616.6
• DOI: 10.1097/SPV.0000000000000795
• Languages: English
• ISSNs: 2151-8378

Abstract

Abstract : Introduction: Malpractice litigations have significant implications for patients and physicians. Studies have investigated mesh litigations in female pelvic reconstructive surgery, but none on nonmesh pelvic organ prolapse (POP) surgery. Our purpose is to determine the reasons for and outcomes of medical malpractice after nonmesh POP surgery. Methods: Westlaw (Thompson Reuters, New York, New York) is a legal research database of US court records. We identified completed POP litigations from 1987 to 2018 using the following: "pelvic organ prolapse, " "enterocele, " "rectocele, " "cystocele, " "uterine prolapse, " and "vaginal wall prolapse." Mesh-related cases were excluded. Outcomes included reasons for litigation, verdict, injury, and payments. Statistical analysis was performed with nonparametric tests and χ 2 independence test. Results: Ninety-one litigations were included. The median plaintiff age was 53 years (range, 36–85 years). The leading allegation was negligence of surgery (n = 59; 65%). The jury sided with the defendant physician in 67% of cases (n = 61). There was no association between case verdict and patient age ( P = 0.781), geographic region ( P = 0.824), or allegation ( P = 0.904). The primary complications were urinary tract injury (n = 24; 26%), need for additional surgery (n = 22; 24%), and new postoperative urinary symptoms (n = 22; 24%). The median payout was $280, 000 (interquartile range, $137, 250–$1, 300, 000), with no difference between plaintiff awards or settlements ( P = 0.659). Conclusion: The leading allegation of malpractice litigations for nonmesh POP surgery is negligence of surgery, whereas the most common complication was urinary tract injury. A verdict in favor of the physician defendant was the most likely outcome. Plaintiff awards and settlements were not statistically different with no variation by region or time.